This clinical trial collects blood, saliva, urine, or stool samples to help identify possible genetic mutations that may increase a person's chance at developing pancreatic cancer. Finding genetic markers among pediatric patients with acute recurrent pancreatitis and chronic pancreatitis may help identify patients who are at risk of pancreatic cancer.
All subjects/parents must sign an informed consent and/or assent indicating that they are aware of the investigational nature of this study
Subjects/parents must have signed an authorization for the release of their or their child's protected health information
All children must be under 18 years of age at the time of enrollment
Abdominal pain compatible with AP
Subjects must not have any significant medical illnesses that in the investigator's opinion cannot be adequately controlled with appropriate therapy or would compromise the subject's ability to tolerate study interventions
M.D. Anderson Cancer Center
Lead sponsor
National Cancer Institute (NCI)
Collaborator